Skip to content

clinical randomized controlled trial on treatment of ascites due to hepatitis B by grain-sized moxibustion

clinical randomized controlled trial on treatment of ascites due to hepatitis B by grain-sized moxibustion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006854
Enrollment
Unknown
Registered
2022-12-06
Start date
2022-12-10
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhotic ascites

Interventions

The treatment group:moxibustion with seed-sized moxa cone based on conventional treatment

Sponsors

The Fifth Medical Center of the General Hospital of the People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients who meet the Western diagnostic criteria for ascites of hepatitis B cirrhosis; (2) Men and women aged 18-75; (3) Patients voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: Those who meet the inclusion criteria but meet one of the following conditions are excluded: (1) Patients with unconsciousness, unable to express subjective discomfort symptoms and mental patients; (2) Patients with heart failure, respiratory failure, severe renal insufficiency and other serious infectious diseases; (3) Patients with severe bleeding tendency. (4) Patients with diabetic foot. (5) Pregnant and lactating women; (6) Other conditions in which other clinical investigators are engaged or in which the investigator deems it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
abdomen circumference;weight;24-hour urine output;

Countries

China

Contacts

Public Contactlijun/zhouchao
liyushana@163.com15210976313

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026